News | News By Subject | News by Disease News By Date | Search News

Typhoid fever News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web

Press Releases
Fyodor Biotechnologies, Inc. Awarded SBIR Phase 2 Grant to Develop a Urine-Based Multi-Disease Test for Acute Febrile Illness     10/1/2013
DelSite Biotechnologies, Inc. Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate     6/26/2008
Emergent BioSolutions (EBS) Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate     6/5/2008
Emergent BioSolutions (EBS) Announces That the Final Phase II Clinical Study Results for Typhoid Vaccine Reaffirms Clinical Endpoints Met; Immune Response Seen in 97% of Treated Subjects     1/9/2008
Emergent BioSolutions (EBS) Announces That the Final Phase II Clinical Study Results for Typhoid Vaccine Reaffirms Clinical Endpoints Met; Immune Response Seen in 97% of Treated Subjects     1/8/2008
Emergent BioSolutions (EBS)' Typhoid Vaccine Candidate Achieves Endpoints in Phase II Clinical Study     10/10/2007
Avant Immunotherapeutics (AVAN) Commences Phase 2 Clinical Trial of Its Single Dose, Oral Typhoid Fever Vaccine     7/30/2007
Avant Immunotherapeutics (AVAN) Receives National Institutes of Health (NIH) SBIR Phase 2 Award For Development And Manufacture Of Ty800 With VitriLife(R)     9/27/2006
Avant Immunotherapeutics (AVAN) Announces Start Of Phase I/II Clinical Trial Of Its Typhoid Fever Vaccine     2/14/2006
Emergent BioSolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study     8/30/2005

//-->